SERPINB7 Expression Predicts Poor Pancreatic Cancer Survival Upon Gemcitabine Treatment

Stratification of patients with pancreatic ductal adenocarcinoma (PDAC) remains a key challenge in the field of clinical oncology. No predictive biomarkers have yet been found for any available treatment options. Previously, we identified SERPINB7 as a putative biomarker for PDAC and thus, herein, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Bianconi, Daniela, Herac, Merima, Spies, Daniel, Kieler, Markus, Brettner, Robert, Unseld, Matthias, Fürnkranz, Katrin, Famler, Barbara, Schmeidl, Margit, Minichsdorfer, Christoph, Zielinski, Christoph, Heller, Gerwin, Prager, Gerald W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2018
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149193/
https://www.ncbi.nlm.nih.gov/pubmed/30245304
http://dx.doi.org/10.1016/j.tranon.2018.08.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6149193/
https://www.ncbi.nlm.nih.gov/pubmed/30245304
http://dx.doi.org/10.1016/j.tranon.2018.08.019

Ejemplares similares